Pluri Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pluri Inc. on December 19, 2022, covering events occurring between December 13, 2022, and December 19, 2022. The Company, incorporated in Nevada and headquartered in Haifa, Israel, operates on The Nasdaq Global Market under the symbol PLUR.
Key Financial Metrics and Capital Structure
The filing details a private placement offering (the "Offerings") executed with accredited and non-U.S. investors. The Company agreed to sell an aggregate of 8,020,900 Common Shares and corresponding Warrants to purchase up to 8,020,900 Common Shares. The transaction was structured across four tranches with varying purchase prices:
- December 13, 2022: Up to 5,579,883 shares and warrants at $1.03 per share.
- December 14, 2022: Up to 2,068,517 shares and warrants at $1.05 per share.
- December 15, 2022: Up to 237,500 shares and warrants at $1.06 per share.
- December 19, 2022: Up to 135,000 shares and warrants at $1.09 per share.
All Warrants have an exercise price equal to the respective purchase price and a three-year term. They are exercisable upon the later of six months from issuance or the Company's increase of authorized shares. The filing does not provide specific revenue, profit, cash flow, or debt figures for the reporting period.
Material Changes and Executive Compensation
On December 14, 2022, the Company entered into a compensatory arrangement with Chief Executive Officer Yaky Yanay. Effective January 1, 2023, Mr. Yanay agreed to forgo $375,000 of his annual cash salary for the next twelve months in exchange for equity grants. The compensation package includes:
- 334,821 Restricted Stock Units (RSUs) vesting ratably monthly.
- Options to purchase 334,821 Common Shares at $1.12 per share, vesting ratably monthly.
- Options to purchase 1,500,000 Common Shares with tiered exercise prices ($1.56, $2.08, and $2.60) and vesting schedules tied to June 30, 2023, and December 31, 2023.
All options are expected to be issued in January 2023 and are exercisable on the later of their vesting date or the increase of authorized share capital.
Outlook, Risks, and Contingencies
The Offerings are expected to close between December 15, 2022, and January 31, 2023. A material contingency exists regarding the Company's authorized share capital; the securities issued are subject to the Company increasing its authorized shares. To facilitate this, purchasers agreed to execute proxies allowing the CEO and CFO to vote in favor of a future increase in authorized shares. The Company has agreed to hold a shareholder meeting within 200 days of the agreement execution for this purpose. The securities are exempt from registration under Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D and Regulation S.
Investor Verification Checklist
- Verify the final closing date and total proceeds received from the private placement offering.
- Confirm the outcome of the shareholder vote required to increase authorized shares within the 200-day window.
- Monitor the issuance of the CEO's equity grants and the impact of the $375,000 salary reduction on cash flow.
- Review the full text of the Securities Purchase Agreements and Warrants filed as Exhibits 10.1 and 4.1 for specific covenants.